Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox

INTRODUCTION: Monkeypox was originally endemic locally in West Africa; however, outbreaks in non-endemic countries have been recognised since May 2022. The effectiveness of tecovirimat has been estimated against smallpox, which belongs to the same Orthopoxvirus genus as monkeypox. Thus, tecovirimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Tetsuya, Saito, Sho, Tsuzuki, Shinya, Ashida, Shinobu, Takakusaki, Mizue, Yoshikawa, Tomoki, Shimojima, Masayuki, Ebihara, Hideki, Ohmagari, Norio, Morioka, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394549/
https://www.ncbi.nlm.nih.gov/pubmed/37527886
http://dx.doi.org/10.1136/bmjopen-2022-069550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394549/
https://www.ncbi.nlm.nih.gov/pubmed/37527886
http://dx.doi.org/10.1136/bmjopen-2022-069550

Ejemplares similares